LU92134I2 - Ceftaroline fosamil et ses dérivés pharmaceutiquement acceptables (ZINFORO) - Google Patents

Ceftaroline fosamil et ses dérivés pharmaceutiquement acceptables (ZINFORO)

Info

Publication number
LU92134I2
LU92134I2 LU92134C LU92134C LU92134I2 LU 92134 I2 LU92134 I2 LU 92134I2 LU 92134 C LU92134 C LU 92134C LU 92134 C LU92134 C LU 92134C LU 92134 I2 LU92134 I2 LU 92134I2
Authority
LU
Luxembourg
Prior art keywords
zinforo
pharmaceutically acceptable
acceptable derivatives
ceftaroline fosamil
fosamil
Prior art date
Application number
LU92134C
Other languages
English (en)
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18417716&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU92134(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of LU92134I2 publication Critical patent/LU92134I2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65613—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. cephalosporins and analogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
LU92134C 1997-12-19 2013-01-16 Ceftaroline fosamil et ses dérivés pharmaceutiquement acceptables (ZINFORO) LU92134I2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP35149997 1997-12-19

Publications (1)

Publication Number Publication Date
LU92134I2 true LU92134I2 (fr) 2013-03-18

Family

ID=18417716

Family Applications (1)

Application Number Title Priority Date Filing Date
LU92134C LU92134I2 (fr) 1997-12-19 2013-01-16 Ceftaroline fosamil et ses dérivés pharmaceutiquement acceptables (ZINFORO)

Country Status (19)

Country Link
US (1) US6417175B1 (fr)
EP (2) EP2080765A1 (fr)
JP (3) JP3467418B2 (fr)
KR (1) KR100384047B1 (fr)
CN (2) CN1679595B (fr)
AT (1) ATE430155T1 (fr)
AU (1) AU1683299A (fr)
BE (1) BE2013C004I2 (fr)
CA (1) CA2314564C (fr)
CY (2) CY1109276T1 (fr)
DE (1) DE69840796D1 (fr)
DK (1) DK1043327T3 (fr)
ES (1) ES2325139T3 (fr)
FR (1) FR13C0008I2 (fr)
LU (1) LU92134I2 (fr)
NL (1) NL300568I2 (fr)
PT (1) PT1043327E (fr)
TW (1) TW473479B (fr)
WO (1) WO1999032497A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2323759T3 (es) 2000-08-10 2009-07-24 Takeda Pharmaceutical Company Limited Compuesto de fosfonocefem.
US20070238720A1 (en) * 2005-05-10 2007-10-11 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
US20070249577A1 (en) * 2005-05-10 2007-10-25 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
US20070238719A1 (en) * 2005-05-10 2007-10-11 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
CN101357929B (zh) * 2007-06-22 2010-12-15 山东轩竹医药科技有限公司 含有巯基噻二唑的头孢菌素衍生物
CN103919720A (zh) * 2007-09-21 2014-07-16 阿斯利康(瑞典)有限公司 适合肠胃外给药的包含头孢烯衍生物的可溶剂型
KR101783573B1 (ko) * 2008-08-28 2017-09-29 아스트라제네카 아베 세프타롤린을 포함하는 조성물 및 치료 방법
CA2753387C (fr) * 2009-02-23 2017-01-24 Forest Laboratories Holdings Limited Nouveaux composes de cepheme utiles pour le traitement d'infections bacteriennes
AU2010295269B2 (en) 2009-09-21 2014-06-05 Pfizer Anti-Infectives Ab Compositions and methods for treating bacterial infections using ceftaroline
FR2951171A1 (fr) 2009-10-09 2011-04-15 Novexel Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation
MX361020B (es) 2011-06-17 2018-11-26 Pfizer Anti Infectives Ab Procesos para preparar compuestos heterociclicos, incluida trans-7-oxo-6-(sulfooxi)-1,6-diazabiciclo [3,2,1]octano-2-carboxam ida y sales de la misma.
US20140350240A1 (en) 2011-12-07 2014-11-27 Ranbaxy Laboratories Limited Process for preparing ceftaroline salts or hydrates thereof
EP2909219B1 (fr) * 2012-10-19 2019-02-13 Sandoz AG Nouveau procédé pour la préparation de ceftaroline fosamil
CN102977124B (zh) * 2012-12-13 2014-11-26 山东诚创医药技术开发有限公司 7β-[(苯乙酰)氨基]-3-[4-(1-甲基-4-吡啶鎓)-2-噻唑硫基]-3-头孢烯-4-羧酸二苯甲基酯的制备方法
CN104870457B (zh) * 2012-12-20 2017-08-08 桑多斯股份公司 头孢洛林酯的新晶形
ES2900838T3 (es) 2014-02-21 2022-03-18 Shanghai Micurx Pharmaceutical Co Ltd Profármacos de O-carbonil fosforamidato solubles en agua para administración terapéutica
CN106565784B (zh) * 2016-10-31 2019-02-26 瑞阳制药有限公司 头孢洛林酯二钠盐的纯化方法
CN110872322B (zh) * 2018-08-29 2022-08-02 上海博志研新药物技术有限公司 乙酸头孢罗膦一水合物及其中间体的制备方法
CN113072567B (zh) * 2021-03-26 2022-10-14 海南海灵化学制药有限公司 一种拉氧头孢钠合成工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5941999B2 (ja) 1975-07-24 1984-10-11 武田薬品工業株式会社 セフエムまたはベナム化合物の製造法
JPS5511600A (en) * 1978-07-10 1980-01-26 Fujisawa Pharmaceut Co Ltd Cephem compound, its salt, their preparation and remedy and prophylactic for microbism containing mainly the same
US4268509A (en) 1978-07-10 1981-05-19 Fujisawa Pharmaceutical Co., Ltd. New cephem compounds and processes for preparation thereof
FR2511372A1 (fr) * 1981-08-17 1983-02-18 Rhone Poulenc Sante Nouveaux derives de la cephalosporine et leur preparation
US4563449A (en) * 1982-07-19 1986-01-07 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
JPS5931791A (ja) * 1982-07-19 1984-02-20 Fujisawa Pharmaceut Co Ltd 新規セフエム化合物およびその製造法、並びに細菌感染症予防・治療剤
JPS62238291A (ja) * 1986-04-10 1987-10-19 Fujisawa Pharmaceut Co Ltd セフエム化合物および医薬として許容されるその塩
US4978663A (en) * 1989-08-16 1990-12-18 Hoechst-Roussel Pharmaceuticals Inc. 5-(1-aminocyclohexyl)-2(1H)-pyridinone compounds which have pharmaceutical utility
JP3514495B2 (ja) 1992-10-02 2004-03-31 エーザイ株式会社 ハロゲン化アミノチアジアゾリル酢酸誘導体の製造法
JP3927262B2 (ja) * 1995-07-19 2007-06-06 武田薬品工業株式会社 セフェム化合物、その製造法および抗菌組成物
JPH10265488A (ja) * 1997-03-27 1998-10-06 Takeda Chem Ind Ltd ホスフォノセフェム誘導体

Also Published As

Publication number Publication date
CY2013003I1 (el) 2014-07-02
DE69840796D1 (de) 2009-06-10
CN1679595B (zh) 2010-05-12
CN1679595A (zh) 2005-10-12
CY1109276T1 (el) 2014-07-02
ATE430155T1 (de) 2009-05-15
JP2009114202A (ja) 2009-05-28
CN1194980C (zh) 2005-03-30
KR20010015885A (ko) 2001-02-26
WO1999032497A1 (fr) 1999-07-01
CA2314564C (fr) 2008-11-18
AU1683299A (en) 1999-07-12
US6417175B1 (en) 2002-07-09
NL300568I1 (fr) 2016-01-18
JPH11255772A (ja) 1999-09-21
CY2013003I2 (el) 2015-08-05
DK1043327T3 (da) 2009-08-17
PT1043327E (pt) 2009-07-02
FR13C0008I2 (fr) 2013-08-16
KR100384047B1 (ko) 2003-05-14
NL300568I2 (fr) 2016-01-18
EP1043327A1 (fr) 2000-10-11
JP2001048893A (ja) 2001-02-20
BE2013C004I2 (en) 2018-01-29
EP2080765A1 (fr) 2009-07-22
TW473479B (en) 2002-01-21
EP1043327A4 (fr) 2001-12-12
FR13C0008I1 (fr) 2013-03-22
EP1043327B1 (fr) 2009-04-29
ES2325139T3 (es) 2009-08-26
JP3467418B2 (ja) 2003-11-17
CN1282335A (zh) 2001-01-31
CA2314564A1 (fr) 1999-07-01

Similar Documents

Publication Publication Date Title
LU92134I2 (fr) Ceftaroline fosamil et ses dérivés pharmaceutiquement acceptables (ZINFORO)
HUT59109A (en) Process for producing hydroxymethyl-(methylenecyclopentyl)-purines and -pyrimidines, their pharmaceutically acceptable salts and pharmaceutical compositions comprising same
IL114735A0 (en) L-monovaline ester of a purine derivative its preparation and pharmaceutical compositions containing it
HUT68602A (en) Triazolylthiomethylthio cephalosporin hydrochloride, its crystalline hydrate and the production of the same
CA2011329A1 (fr) Derives de xanthine
HK62797A (en) A pharmaceutical solution comprising derivatives of FK506
AU2323095A (en) Lactam derivatives useful for pharmaceutical purposes
ATE97810T1 (de) Injizierbare cephalosporinpraeparate und ihre anwendung.
EP0481756A3 (en) Benzamide derivatives
EP0416810A3 (en) Cephalosporin compounds, process for their preparation, pharmaceutical compositions and intermediates
HUT76480A (en) Alkyl-5-methyl-sulphonyl-benzoyl-guanidine derivatives, process for the preparation thereof and pharmaceutical compositions containing them
EP0416814A3 (en) Cephalosporin compounds, process for their preparation, pharmaceutical compositions and intermediates
IL99369A0 (en) Pharmaceutical compositions containing substituted 2-cyclohexene derivatives